measurements were made before and after 12 weeks of treatment with piretanide monosubstance ( including the retarded form ) in the range 3 to 12 mg daily , with triamterene as monosubstance and in fixed dose combination with piretanide , and with amiloride in combination with hydrochlorothiazide .
C0040869
triamterene
C0002502
amiloride